Early breast cancer in the elderly: Assessment and management considerations

Drugs and Aging

Volumn 25, Issue 1, 2008, Pages 35-45

  Albrand, Gilles ^a,c   Terret, Catherine ^b  

^a HOSPICES CIVILS DE LYON   (France)

^b CENTRE LÉON BÉRARD   (France)

^c Hopital Geriatrique Antoine Charial   (France)

Author keywords

Aromatase inhibitors, therapeutic use; Breast cancer, treatment; Elderly; Radiotherapy; Surgery; Tamoxifen, therapeutic use

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; HORMONE RECEPTOR; LETROZOLE; METHOTREXATE; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; BONE DENSITY; BREAST CANCER; CANCER CENTER; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; DATA ANALYSIS; DECISION MAKING; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; ENDOMETRIUM CANCER; FOLLOW UP; FRACTURE; GERIATRICS; HEALTH CARE FACILITY; HORMONAL THERAPY; HOT FLUSH; HUMAN; LIFE EXPECTANCY; MASTECTOMY; MUSCULOSKELETAL DEVELOPMENT; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PHYSICIAN; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; VENOUS THROMBOEMBOLISM;

EID: 38049046599     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200825010-00004     Document Type: Review

References (77)

1. Alberg AJ, Singh S. Epidemiology of breast cancer in older women. Drugs Aging 2001; 18: 761-72
2. Bouchardy C, Rapiti E, Fioretta G, et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003; 21: 3580-7
3. Giordano SH, Hortobagyi GN, Kau SWC, et al. Breast cancer treatment guidelines in older women. J Clin Oncol 2005; 23: 783-91
4. Hebert-Croteau N, Brisson J, Latreille J, et al. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 1999; 85: 1104-13
5. Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1973-1997. Bethesda (MD): National Cancer Institute, 2000
6. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 2750-6
7. Rosen PP, Groshen S, Saigo PE, et al. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989; 7: 355-66
8. National Cancer Institute. Dictionary of cancer terms [online]. Available from URL: http://www.cancer.gov/dictionary/ [Accessed 2007 Nov 30]
9. Balducci L, Yates J. General guidelines for the management of older patients with cancer. Oncology 2000; 14: 221-7
10. Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005; 55: 241-52
11. Rubenstein LZ. Geriatric assessment: an overview of its impacts. Clin Geriatr Med 1987; 3: 1-15
12. Winograd CH, Gerety MB, Chung M, et al. Screening for frailty: criteria and predictors of outcomes. J Am Geriatr Soc 1991; 39: 778-84
13. Wieland D, Hirth V. Comprehensive geriatric assessment. Cancer Control 2003; 10: 454-62
14. Rubenstein LZ, Josephson KR, Wieland GD, et al. Effectiveness of a geriatric evaluation unit: a randomised clinical trial. N Engl J Med 1984; 311: 1664-70
15. Landefeld CS, Palmer RM, Kresevic DM, et al. A randomised trial of care in a hospital medical unit especially designed to improve the functional outcomes of acutely ill older patients. N Engl J Med 1995; 332: 1338-44
16. Hogan BD, Fox RA, Badley BW, et al. Effect of a geriatric consultation service on management of patients in an acute care hospital. CMAJ 1987; 136: 713-7
17. Hogan DB, Fox RA. A prospective controlled trial of a geriatric consultation team in an acute-care hospital. Age Aging 1990; 19: 107-13
18. Boult C, Boult L, Murphy C, et al. A controlled trial of outpatient geriatric evaluation and management. J Am Geriatr Soc 1994; 42: 465-70
19. Silverman M, Musa D, Martin DC, et al. Evaluation of outpatient geriatric assessment: a randomized multi-site trial. J Am Geriatr Soc 1995; 43: 733-40
20. Vetter NJ, Jones DA, Victor CR. Effect of health visitors working with elderly patients in general practice: a randomised controlled trial. BMJ 1984; 288: 369-72
21. Hendriksen C, Lund E, Stromgard E. Consequences of assessment and intervention among elderly people: a three-year randomised controlled trial. BMJ 1984; 289: 1522-4
22. Epstein AM, Hall JA, Fretwell M, et al. Consultative geriatric assessment for ambulatory patients: a randomised trial in health maintenance organization. JAMA 1990; 263: 538-44
23. Teasdale TA, Shuman L, Snow E, et al. A comparison of placement outcomes of geriatric cohorts receiving care in a geriatric assessment unit and on general medicine floors. J Am Geriatr Soc 1983; 31: 529-34
24. Reuben DB, Borok GM, Wolde-Tsadik G, et al. A randomised trial of comprehensive assessment in the care of hospitalized patients. N Engl J Med 1995; 332: 1345-50
25. Winograd CH, Gerety MB, Lai NA. A negative trial of inpatient geriatric consultation. Arch Intern Med 1993; 153: 2017-23
26. Stuck AE, Siu AL, Wieland GD, et al. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993; 342: 1032-6
27. Fretwell MD, Raymond PM, McGarvey T, et al. The Senior Care Study: a controlled trial of a consultative/unit-based geriatric assessment program in acute care. J Am Geriatr Soc 1990; 38: 1073-81
28. Reuben DB, Maly RC, Hirsch SH, et al. Physician implementation of and patient adherence to recommendations from comprehensive geriatric assessment. Am J Med 1996; 100: 444-51
29. Luk JK, Or KH, Woo J, et al. Using the comprehensive geriatric assessment technique to assess elderly patients. Hong Kong Med J 2000; 6: 93-8
30. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120: 104-10
31. Yancik R, Wesley MN, Ries LA, et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001; 285: 885-92
32. Carey EC, Walter LC, Lindquist K, et al. Development and validation of a functional morbidity index to predict mortality in community-dwelling elders. J Gen Intern Med 2004; 19: 1027-33
33. Lee SJ, Lindquist K, Segal MR, et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295: 801-8
34. Extermann M, Meyer J, McGinnis M, et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol 2003; 49: 69-75
35. Albrand G, Terret C, Mignotte H, et al. Cancer in older patients: early breast cancer in elderly women. The value of Comprehensive Geriatric Assessment (CGA) [abstract]. Proc Am Soc Clin Oncol 2005; 23: 771
36. Yancik RM, Ries LG, Yates JW. Breast cancer in aging women: a population-based study of contrast in stage, surgery and survival. Cancer 1989; 63: 976-81
37. Rosenkranz KM, Bedrosian I, Feng L, et al. Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center. Am J Surg 2006; 192: 541-4
38. Bergman L, Kluck HM, van Leeuwen FE. The influence of age on treatment choice and survival. Eur J Cancer 1992; 28A: 1475-80
39. Kemeny MM, Busch-Devereaux E, Merriam LT, et al. Cancer surgery in the elderly. Hematol Oncol Clin North Am 2000; 14: 169-92
40. Singletary SE, Shallenberger R, Guinee VF. Breast cancer in the elderly. Ann Surg 1993; 218: 667-71
41. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med 1995; 333: 1444-55
42. Cyran EM, Crane LA, Palmer L. Physician sex and other factors associated with type of breast cancer surgery in older women. Arch Surg 2001; 136: 185-91
43. Audisio RA, Bozzetti F, Gennari R, et al. The surgical management of elderly cancer patients: recommendations of the SIOG surgical task force. Eur J Cancer 2004; 40: 926-38
44. Mandelblatt JS, Kerner JF, Hadley J, et al. Variations in breast carcinoma treatment in older Medicare beneficiaries: is it black or white? Cancer 2002; 95: 1401-14
45. Martelli G, Miceli R, De Palo G, et al. Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla. Cancer 2003; 97: 1156-63
46. Hind D, Wyld L, Beverley CB, et al. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). Cochrane Database Syst Rev 2006; (1): CD004272
47. Veronesi U, Banfi A, Salvadori B, et al. Breast conservation is the treatment of choice in small breast cancer: long term-results of a randomized trial. Eur J Cancer 1990; 26: 668-70
48. Nemoto T, Patel JK, Rosner D, et al. Factors affecting recurrence in lumpectomy without irradiation for breast cancer. Cancer 1991; 67: 2079-82
49. Clark RM, McCulloch PB, Levine MN. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992; 84: 683-9
50. Smith BD, Gross CP, Smith GL, et al. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 2006; 98: 681-90
51. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004; 351: 963-70
52. Vinh-Hung V, Burzykowski T, Van de Steene J, et al. Post-surgery radiation in early breast cancer: survival analysis of registry data. Radiother Oncol 2002; 64: 281-91
53. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004; 351: 971-7
54. Wyckoff J, Greenberg H, Sanderson R, et al. Breast irradiation in the older woman: a toxicity study. J Am Geriatr Soc 1994; 42: 150-2
55. Witherby SM, Muss H. Managing early-stage breast cancer in your older patients. Oncology 2006; 20: 1003-12
56. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000; 97: 550-6
57. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-survival: an overview of the randomised trials. Lancet 2005; 635: 1687-717
58. Silliman RA, Guadagnoli E, Rakowski W, et al. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol 2002; 20: 2680-8
59. Demissie S, Silliman RA, Lash TL. Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 2001; 19: 322-8
60. Perez EA. Appraising adjuvant aromatase inhibitor therapy. Oncologist 2006; 11: 1058-69
61. Howell A, Cuzick J, Baum M, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005; 365: 60-2
62. Thürlimann B, Keshaviah A, Coates AS, et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005; 353: 2747-57
63. Jakesz R, Jonat W, Gnant M, et al. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 2005; 366: 455-62
64. Boccardo F, Rubagotti A, Puntoni M, et al. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial. J Clin Oncol 2005; 23: 5138-47
65. Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004; 350: 1081-92
66. Goss PE, Ingle JN, Martino S, et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 2005; 97: 1262-71
67. Winer EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 2005; 23: 619-29
68. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16: 1569-83
69. Hillner BE, Ingle JN, Chlebowski RT, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003; 21: 4042-57
70. Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004; 22: 4626-31
71. Kemeny MM, Peterson BL, Kornblith AB, et al. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 2003; 21: 2268-75
72. Fisher B, Jeong JH, Bryant J, et al. Treatment of lymph nodenegative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet 2004; 364: 858-68
73. International Breast Cancer Study Group. Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst 2002; 94: 1054-65
74. Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005; 293: 1073-81
75. Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999; 17: 1080-2
76. Brunello A, Basso U, Pogliani C, et al. Adjuvant chemotherapy for elderly patients (≥70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients. Ann Oncol 2005; 16: 1276-82
77. Aapro M. Improving bone health in patients with early breast cancer by adding bisphosphonates to letrozole: the Z-ZO-E-ZO-FAST program. Breast 2006; 15 Suppl. 1: S30-40